Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHDT.L Regulatory News (HDT)

  • There is currently no data for HDT

Final Results

11 Feb 2009 07:00

RNS Number : 1007N
Holders Technology PLC
11 February 2009
Β 

ο»Ώ

Holders Technology plc

Providers ofΒ specialisedΒ materials, equipment and servicesΒ toΒ the electronicsΒ industry

Audited results for the year ended 30 NovemberΒ 2008

Holders Technology plcΒ ("Holders Technology" or "the group")Β announcesΒ itsΒ audited results for the year endedΒ 30 NovemberΒ 2008.

The printed circuit boardΒ (PCB)Β industryΒ reflected the decline inΒ the world economy during 2008. Holders Technology achieved the following results in a difficult market:

β€’ Revenue declined 7.3% to Β£17.5mΒ (2007: Β£18.9m)

β€’ Gross profit of Β£4.4m (2007: Β£5.0m)

β€’ Operating profit before exceptional items fell from Β£1.2m to Β£0.7m

β€’ Β£1.3m positive cash flow generated from operations

β€’ Restructuring of Swedish operation

β€’ Β£0.1m non-cash write down of goodwillΒ and investments

β€’ Net cash of Β£1.5mΒ at year end (2007: Β£1.1m)

β€’ Proposed unchanged final dividend of 3.25p

Chairman's statement

IΒ cautionedΒ in previous Chairman's Statements that the year to 30 November 2008 would be unlikely to match the preceding year and this proved to be the case. Our markets weakened further in the second half of the year,Β particularly in Sweden and Germany. The end users served by our European subsidiaries vary from country to country, so we outline each of these markets as follows:.

The UKΒ PCBΒ marketΒ has a marked bias towards the aerospace and industrial electronics industries and these haveΒ shown more resilience thanΒ consumer related marketsΒ to date. OurΒ UKΒ operations produced a good performance for the year.

Our German subsidiary's sales are heavily influenced by production levels in the car industry and severely reduced volumes in that industry during the latter part of the yearΒ inevitablyΒ had a significant impactΒ on operations. Despite this,Β trading for the year remained profitable.

The Dutch subsidiary has exposure to the general industrial market and to medical equipment manufacturers. Whilst the latter experienced normal trading in the year there was marked softening in the general industrial market. Despite this weakening, our Dutch subsidiaryΒ remained profitable for the year.

Our Swedish subsidiary, serving the Scandinavian market, has for some years felt the impact of the major Scandinavian telecommunication companies switching their sourcing of PCBs to the Far East. This subsidiary was unprofitable in the year to 30 November 2008. We have reshaped our Scandinavian activities to ensure continued sales coverage of this market but at a significantly reduced cost. The cost of these changes is contained in the accounts for the year. Outside of Europe our geographical coverage extends to China and India. The Chinese PCB market is very consumer product focused and dependent on exports. Recent changes within this market have had adverse implications for our subsidiary and we are examining its present structure. Our Indian joint venture, whilst small, is holding its ground and continuing to make progress in widening its product range.

Β 

During the yearΒ to November 2008Β we maintained a determined focus onΒ minimisingΒ overheads; thisΒ hasΒ enabled us, in part, to offset the adverse impact of volume declines. However despite prudential hedging of currency exposures we were unable totally to offset the impact of exchange movements and margins were adversely affected in the year.

The strength of theΒ euro against the pound increased the net asset values of our European subsidiaries, when translated into sterling. This contributed to the increase in the group's tangibleΒ netΒ assetΒ valueΒ fromΒ 123pΒ per shareΒ toΒ 143p per share over the year to 30 November 2008.

Our conservative financial policy has enabled us to maintain a strong, positive cash position, despite the difficultΒ economic times, and I am pleased to confirm that the company will, subject to the approval of shareholders at the Annual General Meeting, pay a final dividend of 3.25p per share (2007: 3.25p per share). The dividend will be paid onΒ 19 May 2009Β to shareholders on the register onΒ 24 April 2009Β and the shares will go ex-dividend onΒ 22 April 2009.

In summary the year to 30 November 2008 was not an easy one for your company and the current year is likely to be even more difficult. The level of turnover we will achieve this year will, in large part, be driven by factors outside our control. WeΒ expect that margins will be under pressure, due to weak demand,Β and it is of particular concern that we are seeing a tightening of the market for credit insurance in respect of ourΒ receivables; this will require even greater vigilance on our part. Should we see any ofΒ our activities not contributing, weΒ willΒ review the possibility of restructuring these. As with our Scandinavian operations this year, there may be one off costs associated with any actions we are obliged to take. Above all we will continue to concentrate on cost containment and cash preservation.

The Board wishes shareholders to be fully aware of the challenges your company faces and currently we consider it likely that the first half of the current yearΒ mayΒ not be profitable. As against thisΒ sombreΒ assessment of our position I am glad to be able to report that we have had an encouraging reception for a major new product line we have added to our range and we expect this to have a positive impact on the second half of the current year.

As a company we have experienced cyclical downturns before and areΒ experienced inΒ addressing the challenges these pose. We fully expect to maintain our position in our key markets and to end the year financially strong.

RΒ W WeinreichΒ 

Chairman and Chief Executive

10 February 2009

Consolidated income statement

for the year ended 30 November 2008

Before exceptionalΒ 

items

ExceptionalΒ items

Total

Total

Note

2008

2008

2008

2007

Β£'000

Β£'000

Β£'000

Β£'000

Continuing operations

Revenue

17,481

-

17,481

18,853

Cost of sales

(13,057)

-

(13,057)

(13,866)

Gross profit

4,424

-

4,424

4,987

Distribution costs

(427)

-

(427)

(463)

Administrative expenses

(3,285)

-

(3,285)

(3,398)

Fundamental restructuring

2

-

(64)

(64)

-

ImpairmentΒ Β of goodwill

2

-

(100)

(100)

-

Impairment of investment in associates

2

-

(51)

(51)

-

Other operating income

11

-

11

76

Operating profit

723

(215)

508

1,202

Finance income

43

-

43

27

Finance expenses

(38)

-

(38)

(23)

Profit before taxation

728

(215)

513

1,206

Taxation

3

(261)

18

(243)

(454)

Profit after taxation

467

(197)

270

752

Attributable to:

Equity shareholders of the company

322

744

Minority interests - equity

(52)

8

Profit for the financial year

270

752

Total and continuing

Basic earnings per share

6

8.21p

17.97p

Diluted earnings per share

6

8.21p

17.78p

Consolidated balance sheet

at 30 November 2008

Group

Company

Note

2008

2007

2008

2007

Β£'000

Β£'000

Β£'000

Β£'000

Assets

Non-current assets

Goodwill

201

397

-

-

Property, plant and equipment

651

622

3

2

Investments in subsidiaries

-

-

2,352

2,580

Investment in joint venture

-

-

15

15

Investments in associates

-

28

-

-

Deferred taxΒ 

31

49

-

4

883

1,096

2,370

2,601

Current assets

Inventories

2,808

2,645

-

-

Trade and other receivables

2,700

2,588

472

345

Current tax

99

-

16

-

Cash and cash equivalents

1,774

1,275

297

669

7,381

6,508

785

1,014

Liabilities

Current liabilities

Trade and other payables

(1,663)

(1,399)

(377)

(654)

Borrowings

(237)

(174)

-

-

Current taxΒ 

(33)

(275)

-

(22)

(1,933)

(1,848)

(377)

(676)

Net current assets

5,448

4,660

408

338

Non-current liabilities

Retirement benefit liability

(165)

(139)

-

-

Deferred consideration

-

(104)

-

(104)

(165)

(243)

-

(104)

6,166

5,513

2,778

2,835

Shareholders' equity

Share capital

4

416

416

416

416

Share premium account

4

1,531

1,531

1,531

1,531

Capital redemption reserve

4

1

1

1

1

Retained earnings

4

3,568

3,431

830

887

Cumulative translation adjustmentΒ reserve

4

520

37

-

-

Equity attributable to the equity shareholders

6,036

5,416

2,778

2,835

Minority interests in equity

4

130

97

-

-

6,166

5,513

2,778

2,835

Consolidated cash flowΒ statement

forΒ the year ended 30 November 2008

Group

Company

Note

2008

Β 2007

2008

Β 2007

Β£'000

Β£'000

Β£'000

Β£'000

Cash flows from operating activities

Operating profit

508

1,202

(120)

(78)

Share-based payment charge

12

12

12

12

Depreciation

184

288

1

-

Impairment of goodwill

100

-

-

-

Impairment of investment in associate

51

-

-

-

Currency translation

293

102

-

-

Loss on sale of property, plant and equipment

2

1

-

-

(Increase)/decrease in inventories

(140)

508

-

-

(Increase)/decrease in trade and other receivables

(86)

231

(266)

485

(Increase)/decrease in trade and other payables

349

(362)

(277)

259

Cash generated from operations

1,273

1,982

(650)

678

Corporation tax paid

(566)

(418)

(46)

(35)

Net cash generated from operations

707

1,564

(696)

643

Cash flows from investing activities

Proceeds from disposal of investment in associate

-

119

-

-

Increase in investment inΒ associate

(23)

-

-

-

Investment in new subsidiary

-

-

-

(18)

Investment in joint venture

-

-

-

(15)

Purchase of property, plant and equipment

(132)

(403)

(2)

-

Proceeds from sale of property, plant and equipment

24

15

-

-

Income from investments

-

-

499

600

Interest received

43

27

24

25

Net cash generated/(used) in investing activities

(88)

(242)

521

592

Cash flows from financing activities

Proceeds from exercise of employee share options

13

-

13

-

Purchase of treasury shares

-

(398)

-

(398)

Interest paid

(38)

(23)

-

(4)

Equity dividends paid

(210)

(212)

(210)

(212)

Finance lease principal payments

-

(6)

-

-

Net cash used in financing activities

(235)

(639)

(197)

(614)

Net change in cash and cash equivalents

384

683

(372)

621

Cash and cash equivalents at start of period

1,101

418

669

48

Effect of foreign exchange rates

52

-

-

-

Cash and cash equivalents at end of period

1,537

1,101

297

669

NotesΒ 

Basis of preparation

The group and parent company financial statements have been prepared in accordance with EU endorsed International Financial Reporting Standards (IFRS), International Financial Reporting Interpretations Committee (IFRIC) interpretations and with those parts of the Companies Act 1985 applicable to companies reporting under IFRS. All accounting standards and interpretations issued by the International Accounting Standards Board and the International Financial Reporting Interpretations Committee effective at the time of preparing these financial statements have been applied.

Β 

2. Exceptional items

Exceptional items consist of the following:

2008

Β£'000

2007

Β£'000

Fundamental restructuringΒ 

(64)

-

Impairment of goodwill

(100)

-

Impairment of investment in associate

(51)

-

(215)

-

The fundamental restructuring chargeΒ consists ofΒ redundancy and lease termination costs at the group's Swedish operation.

The goodwill impairment charge represents 100% of the goodwill related to Topgrow Technologies Limited (Topgrow), which made a loss of Β£58,000 in 2008 and is not forecast to return to profit in the next two years.

Topgrow's associated companies, WayskyΒ Technology Limited and China Hill Technology Limited had a very difficult year and no audited accounts are available. Accordingly, the group's investment in associates has been written off.

3. Taxation

2008

Β£'000

2007

Β£'000

Analysis of the charge in the period

Current taxΒ 

- Current period

228

381

- Adjustments in respect of prior periods

(3)

87

225

468

Deferred taxΒ 

18

(14)

Total tax

243

454

Tax reconciliation

The tax for the period is higher (2007: higher) than the standard rate of corporation tax in theΒ UK, effectively 28.67% (2007: 30%) for the company's financial year. The differences are explained below:

2008

Β£'000

2007

Β£'000

Profit before taxation

513

1,206

Profit before taxation multiplied by rate of corporation tax in theΒ UKΒ ofΒ 28.67% (2007: 30%)

147

362

Effects of:

Differences between capital allowances and depreciation

(3)

(10)

Amounts not deductible for taxation purposes

79

-

Adjustments in respect of prior years

2

87

Taxation losses

34

15

Other timing differences

(8)

-

Different overseas tax rates

(8)

-

Taxation

243

454

4. Statement of changes in shareholders' equity

GroupΒ 

Capital

Cumulative

Β 

Β Share

Share

redemption

translation

Retained

Shareholders'

Minority

Total

Β capital

premium

reserve

adjustment

earnings

equity

interest

equity

Β Β£'000

Β£'000

Β£'000

Β£'000

Β£'000

Β£'000

Β£'000

Β£'000

Β 

Β 

Balance at 1 DecemberΒ 2006

416

1,531

1Β 

(84)

3,285

5,149Β 

162Β 

5,311Β 

Profit/(loss) for the period

-Β 

-Β 

-Β 

-

744

744Β 

8

752Β 

Dividends

-Β 

-Β 

-Β 

-

(212)Β 

(212)

-Β 

(212)

Purchase of treasury shares

-

-

-

-

(398)

(398)

-

(398)

Currency translation differences

-Β 

-Β 

-Β 

121

-

121

(8)

113

Share-based payment credit

-Β 

-Β 

-Β 

-

12

12

-

12

Transfer in respect of associates

-Β 

-Β 

-Β 

-

-

-

(65)

(65)

Balance at 30 NovemberΒ 2007

416Β 

1,531Β 

1Β 

37

3,431

5,416Β 

97Β 

5,513Β 

Profit/(loss) for the period

-Β 

-Β 

-Β 

-

322

322

(52)

270

Dividends

-Β 

-Β 

-Β 

-

(210)

(210)

-

(210)

Issue of treasury shares

-

-

-

-

13

13

-

13

Currency translation differences

-Β 

-Β 

-Β 

483

-

483

85

568

Share-based payment credit

-Β 

-Β 

-Β 

-

12

12

-

12

Balance at 30 NovemberΒ 2008

416

1,531

1

520

3,568

6,036

130

6,166

Β 

5. The directors have recommended a final dividend ofΒ 3.25p (2007:Β 3.25p) per share payable onΒ 19Β MayΒ 2009Β to shareholders on the register at close of business onΒ 24Β AprilΒ 2009. The total dividend for the year, including the interimΒ dividend of 2.1p (2007: 2.1p) per share paid onΒ 23Β SeptemberΒ 2008, amounts to Β£211,000 (2007: Β£215,000), which is equivalent toΒ 5.35p (2006:Β 5.35p) per share.

Β 

Β 

6. The basic earnings per share are based on the profit for the financial yearΒ attributable to the equity shareholdersΒ of Β£322,000 (2007: Β£744,000) and on ordinary sharesΒ 3,922,611Β (2007: 4,140,085), the weighted average number of shares in issue during the year, excluding treasury shares. Diluted earnings per share are based onΒ 3,922,611Β ordinary shares (2007: 4,183,680), being the weighted average number of ordinary shares after an adjustment ofΒ nilΒ shares (2007:Β 43,595) in relation to share options.

Β 

7. This preliminary statement,Β which has been approved by the Board onΒ 10Β FebruaryΒ 2009,Β is not theΒ Company's statutory accounts. The statutory accounts for each of the two years to 30 NovemberΒ 2007Β and 30 NovemberΒ 2008Β received audit reports, which were unqualified and did not contain statements under section 237 (2) or (3) of the Companies Act 1985. TheΒ 2007Β accounts have been filed with the Registrar of Companies but theΒ 2008Β accounts are not yet filed.

ENDS

Β 

Β 

For further information, contact:

Β 

Holders Technology Plc
020 8731 4336
Mr Rudi Weinreich, Chairman and Chief Executive
Β 
Mr Jim Shawyer, Group Finance Director
Β 
Β 
Β 
Blue Oar Securities Plc - Nomad & Broker
020 7448 4400
Shane Gallwey / Blaine Tatum
Β 

WebsiteΒ www.holderstechnology.com

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
FR UROVRKWRUAAR
Date   Source Headline
21st Jul 20098:17 amPRNHalf-yearly Report
15th Jun 20097:00 amRNSChange of Name of Nominated Adviser and Broker
20th Mar 20097:00 amPRNNotice of AGM
11th Feb 20097:00 amRNSFinal Results
5th Aug 20087:00 amRNSDirector/PDMR Shareholding
16th Jul 20087:00 amRNSInterim Results
17th Mar 20082:58 pmRNSDirector/PDMR Shareholding
19th Feb 20087:00 amRNSFinal Results
13th Feb 20081:08 pmRNSAnnual Report and Accounts
2nd Nov 20074:00 pmRNSCompletion of buy back
1st Nov 20077:01 amRNSProposed share buy back
24th Sep 200710:00 amRNSDirectorate Change
17th Aug 20071:22 pmRNSAIM Rule 26
24th Jul 200711:09 amRNSHolding(s) in Company
18th Jul 20077:00 amRNSInterim Results
9th May 20073:01 pmRNSDirector/PDMR Shareholding
7th Mar 20077:01 amRNSFinal Results
4th Jan 200712:00 pmRNSTrading Statement
19th Dec 20067:00 amRNSAIM Notice 25
15th Aug 200611:39 amRNSAdditional Listing
1st Aug 20067:01 amRNSChange of Adviser
18th Jul 20067:00 amRNSInterim Results
12th Apr 20067:00 amRNSIncrease in investment
15th Mar 20062:12 pmRNSDirector/PDMR Shareholding
9th Mar 20067:01 amRNSFinal Results
19th Dec 200512:23 pmRNSTrading Statement
9th Sep 200510:35 amRNSHolding(s) in Company
12th Aug 20059:16 amRNSDirector/PDMR Shareholding
19th Jul 20057:00 amRNSInterim Results
9th Mar 20057:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.